Skip to main contentSkip to navigationSkip to search
HNSA (, %) SEK
Hansa Biopharma logotype

Directed new share issue by Hansa Medical AB (publ) completed

Regulatory information

On January 9 2012 a Hansa Medical AB (publ) Extraordinary Meeting resolved to follow the proposal of the Board of Directors of Hansa Medical to carry out a directed share issue to NXT2B, the privately owned venture capital firm of Bengt Ågerup. The share issue comprising 5,000,001 shares at the share price SEK 5.50 is now completed and the share issue has provided SEK 27.5 million to Hansa Medical AB (publ). The share issue has increased the company’s share capital by SEK 25,000,005 and today amounts SEK 92,605,725. The total number of outstanding shares is 18,521,145 after the share emission and NXT2B holds 27.0 percent of the outstanding shares.